Skip to main navigation Skip to search Skip to main content

Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma

  • Ola Landgren
  • , Pieter Sonneveld
  • , Andrzej Jakubowiak
  • , Mohamad Mohty
  • , Karim S. Iskander
  • , Khalid Mezzi
  • , David S. Siegel
  • Memorial Sloan-Kettering Cancer Center
  • Erasmus University Rotterdam
  • The University of Chicago
  • Sorbonne Université
  • Amgen Incorporated

Research output: Contribution to journal › Review article › peer-review

52 Scopus citations
Original languageEnglish
Pages (from-to)2127-2143
Number of pages17
JournalLeukemia
Volume33
Issue number9
DOIs
StatePublished - 1 Sep 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this